Stock Research for EVOK

EVOK

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

EVOK Stock Chart & Research Data

The EVOK chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the EVOK chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


EVOK Due diligence Resources & Stock Charts

The EVOK stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View EVOK Detailed Price Forecast - CNN Money CNN View EVOK Detailed Summary - Google Finance
Yahoo View EVOK Detailed Summary - Yahoo! Finance Zacks View EVOK Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View EVOK Trends & Analysis - Trade-Ideas Barrons View EVOK Major Holders - Barrons
NASDAQ View EVOK Call Transcripts - NASDAQ Seeking View EVOK Breaking News & Analysis - Seeking Alpha
Spotlight View EVOK Annual Report - CompanySpotlight.com OTC Report View EVOK OTC Short Report - OTCShortReport.com
TradeKing View EVOK Fundamentals - TradeKing Charts View EVOK SEC Filings - Bar Chart
WSJ View Historical Prices for EVOK - The WSJ Morningstar View Performance/Total Return for EVOK - Morningstar
MarketWatch View the Analyst Estimates for EVOK - MarketWatch CNBC View the Earnings History for EVOK - CNBC
StockMarketWatch View the EVOK Earnings - StockMarketWatch MacroAxis View EVOK Buy or Sell Recommendations - MacroAxis
Bullish View the EVOK Bullish Patterns - American Bulls Short Pains View EVOK Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View EVOK Stock Mentions - StockTwits PennyStocks View EVOK Stock Mentions - PennyStockTweets
Twitter View EVOK Stock Mentions - Twitter Invest Hub View EVOK Investment Forum News - Investor Hub
Yahoo View EVOK Stock Mentions - Yahoo! Message Board Seeking Alpha View EVOK Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for EVOK - SECform4.com Insider Cow View Insider Transactions for EVOK - Insider Cow
CNBC View EVOK Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for EVOK - OTC Markets
Yahoo View Insider Transactions for EVOK - Yahoo! Finance NASDAQ View Institutional Holdings for EVOK - NASDAQ


Stock Charts

FinViz View EVOK Stock Insight & Charts - FinViz.com StockCharts View EVOK Investment Charts - StockCharts.com
BarChart View EVOK Stock Overview & Charts - BarChart Trading View View EVOK User Generated Charts - Trading View




Latest Financial News for EVOK


Evoke Pharma (EVOK) Announces FDA Acceptance of Gimoti NDA
Posted on Friday August 17, 2018

The FDA accepts Evoke Pharma's (EVOK) regulatory application seeking approval of its pipeline candidate, Gimoti, for treating diabetic gastroparesis. Shares up.


Evoke Pharma’s Gimoti™ NDA Accepted for FDA Review
Posted on Thursday August 16, 2018

Evoke Pharma, Inc. (EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that the Company’s 505(b)(2) New Drug Application (NDA) for Gimoti™, the Company’s nasal spray product candidate for the relief of symptoms in adult women with acute and recurrent diabetic gastroparesis, has been accepted for review by the U.S. Food and Drug Administration (FDA). In its Filing Communication/Day-74 letter, FDA stated that the NDA received on June 1, 2018, is sufficiently complete to permit a substantive review and set a target goal date under the Prescription Drug User Fee Act (PDUFA) of April 1, 2019.


Evoke Pharma Reports Second Quarter 2018 Results and Recent Highlights
Posted on Thursday August 09, 2018

Gimoti™ NDA submitted to FDA on June 1 st; awaiting 74- Day FDA filing communication letter. Gender-specific patents granted for Gimoti in the European Union and Mexico. SOLANA BEACH, Calif., Aug. 09, ...


At $2.8701, Is Evoke Pharma Inc (NASDAQ:EVOK) A Buy?
Posted on Wednesday June 06, 2018

Evoke Pharma Inc (NASDAQ:EVOK), a pharmaceuticals company based in United States, received a lot of attention from a substantial price increase on the NasdaqCM over the last few months. WithRead More...


Stock Market & Investing Books

Enter a stock symbol to view the stock details.